Home » Topics » BioWorld Science

BioWorld Science
RSS

NIH awards major grant to ImmunogenX to conduct phase II study for latiglutenase

Aug. 9, 2019

Sesen Bio presents developmental update for Vicinium

Aug. 9, 2019

New selective estrogen receptor modulators disclosed by Radius Pharmaceuticals

Aug. 9, 2019

Immuron reports data from TREAT-003 study of IMM-124-E in severe alcoholic hepatitis

Aug. 9, 2019

TaiGen Biotechnology presents influenza cap-dependent endonuclease inhibitors

Aug. 9, 2019

Kala Pharmaceuticals receives FDA complete response letter for KPI-121 0.25%

Aug. 9, 2019

First patient dosed in phase Ib/IIa PREVAIL study of PRV-3279

Aug. 9, 2019

DPS-2: A dual MEK/ERK and PI3K/AKT inhibitor developed for colorectal cancer

Aug. 9, 2019

89bio initiates phase Ib/IIa study of BIO89-100 for the treatment of NASH

Aug. 9, 2019

ZL-0580: a novel BRD4-selective small molecule that suppresses HIV

Aug. 9, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...